Skip to content

Research on precision prevention technologies for respiratory diseases such as chronic obstructive pulmonary disease based on genetic and environmental risks

Research on precision prevention technologies for respiratory diseases such as chronic obstructive pulmonary disease based on genetic and environmental risks

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108423
Enrollment
Unknown
Registered
2025-08-29
Start date
2025-08-31
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory disease

Interventions

intervention group:The intervention group will receive individualized precision intervention techniques comprising lifestyle modification, pharmacological treatment, and other measures. For smokers, b
Control Group:The control group will receive conventional treatment.

Sponsors

China Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1 Aged 18 to 55 years; 2 Voluntarily participate and able to independently complete all required questionnaires; 3 Willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1 Smokers allergic to nicotine, bupropion hydrochloride, varenicline tartrate, or similar ingredients; 2 Smokers who have received other smoking cessation treatments within the past 30 days; 3 Pregnant or breastfeeding women; 4 Individuals who, in the investigator’s judgment, have other medical conditions or mental states that would prevent them from meeting the study requirements.

Design outcomes

Primary

MeasureTime frame
Lung Function;blood metabolites;CO;

Countries

China

Contacts

Public Contactdan xiao

China Japan Friendship Hospital

danxiao@263.net+86 131 2286 7828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026